Join our community of smart investors

GSK pays its dues

Dodgy marketing practices costs GSK $3bn as the company finally settles with US lawmakers
July 3, 2012

GlaxoSmithKline will pay $3bn (£1.9bn) to settle a long-running lawsuit in the US over its use of dubious marketing practices, which included trying to sell powerful antidepressants to under 18-year-olds.

IC TIP: Buy at 1,469p

The company already made a charge against its accounts last year to cover the fine.